113 related articles for article (PubMed ID: 16782551)
21. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S; Ozcora E; Dirican A
ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):144-50. PubMed ID: 18391573
[TBL] [Abstract][Full Text] [Related]
22. Sublingual immunotherapy mechanisms of action: the role of Th1 response.
Ciprandi G; Tosca MA; Marseglia GL
Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):9-12. PubMed ID: 19944003
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of high-doses sublingual immunotherapy in ultra-rush scheme in children allergic to grass pollen.
Stelmach I; Kaczmarek-Woźniak J; Majak P; Olszowiec-Chlebna M; Jerzynska J
Clin Exp Allergy; 2009 Mar; 39(3):401-8. PubMed ID: 19134016
[TBL] [Abstract][Full Text] [Related]
24. Cost effectiveness of sublingual immunotherapy in children with allergic rhinitis and asthma.
Berto P; Bassi M; Incorvaia C; Frati F; Puccinelli P; Giaquinto C; Cantarutti L; Ortolani C
Eur Ann Allergy Clin Immunol; 2005 Oct; 37(8):303-8. PubMed ID: 17066648
[TBL] [Abstract][Full Text] [Related]
25. Suplatast tosilate affects the initial increase in specific IgE and interleukin-4 during immunotherapy for perennial allergic rhinitis.
Washio Y; Ohashi Y; Tanaka A; Kakinoki Y; Sugiura Y; Sakamoto H; Yamada K; Matsuda M; Uekawa M; Okamoto H; Nakai Y
Acta Otolaryngol Suppl; 1998; 538():126-32. PubMed ID: 9879412
[TBL] [Abstract][Full Text] [Related]
26. Two year follow-up of immunological response in mite-allergic children treated with sublingual immunotherapy. Comparison with subcutaneous administration.
Antúnez C; Mayorga C; Corzo JL; Jurado A; Torres MJ
Pediatr Allergy Immunol; 2008 May; 19(3):210-8. PubMed ID: 18399897
[TBL] [Abstract][Full Text] [Related]
27. Clinical and immunologic effects of sublingual immunotherapy in asthmatic children sensitized to mites: a double-blind, randomized, placebo-controlled study.
Lue KH; Lin YH; Sun HL; Lu KH; Hsieh JC; Chou MC
Pediatr Allergy Immunol; 2006 Sep; 17(6):408-15. PubMed ID: 16925685
[TBL] [Abstract][Full Text] [Related]
28. Sublingual immunotherapy for allergic rhinitis: an update.
Passalacqua G; Compalati E; Canonica GW
Curr Opin Otolaryngol Head Neck Surg; 2011 Feb; 19(1):43-7. PubMed ID: 21102336
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy.
Rossi RE; Monasterolo G; Coco G; Silvestro L; Operti D
Vaccine; 2007 Jan; 25(5):957-64. PubMed ID: 17045368
[TBL] [Abstract][Full Text] [Related]
30. Immunological mechanisms of sublingual immunotherapy.
Akdis CA; Barlan IB; Bahceciler N; Akdis M
Allergy; 2006; 61 Suppl 81():11-4. PubMed ID: 16792600
[TBL] [Abstract][Full Text] [Related]
31. Lung function and cytokine levels in professional athletes.
Rong C; Bei H; Yun M; Yuzhu W; Mingwu Z
J Asthma; 2008 May; 45(4):343-8. PubMed ID: 18446601
[TBL] [Abstract][Full Text] [Related]
32. TGF-beta and IL-17 serum levels and specific immunotherapy.
Ciprandi G; De Amici M; Negrini S; Marseglia G; Tosca MA
Int Immunopharmacol; 2009 Sep; 9(10):1247-9. PubMed ID: 19622397
[TBL] [Abstract][Full Text] [Related]
33. Relationship between soluble HLA-G and HLA-A,-B,-C serum levels, and interferon-gamma production after sublingual immunotherapy in patients with allergic rhinitis.
Ciprandi G; Continia P; Fenoglio D; Sormani MP; Negrini S; Puppo F; Indiveri F
Hum Immunol; 2008 Jul; 69(7):409-13. PubMed ID: 18573288
[TBL] [Abstract][Full Text] [Related]
34. Sublingual immunotherapy reduces allergic symptoms in a mouse model of rhinitis.
Brimnes J; Kildsgaard J; Jacobi H; Lund K
Clin Exp Allergy; 2007 Apr; 37(4):488-97. PubMed ID: 17430344
[TBL] [Abstract][Full Text] [Related]
35. Quality of life outcomes with sublingual immunotherapy.
Wise SK; Woody J; Koepp S; Schlosser RJ
Am J Otolaryngol; 2009; 30(5):305-11. PubMed ID: 19720247
[TBL] [Abstract][Full Text] [Related]
36. Early bronchial involvement in children with allergic rhinitis.
Ciprandi G; Capasso M; Tosca MA
Am J Rhinol Allergy; 2011; 25(1):e30-3. PubMed ID: 21711971
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of sino-nasal polyposis by Candida albicans immunotherapy: apropos of 4 cases].
Bénoliel P
Allerg Immunol (Paris); 2001 Dec; 33(10):388-94. PubMed ID: 11802479
[TBL] [Abstract][Full Text] [Related]
38. Nasal airflow recovery after decongestion test is associated with bronchial hyperreactivity in patients with allergic rhinitis.
Ciprandi G; Cirillo I; Klersy C; Vizzaccaro A; Tosca MA; Marseglia GL
Otolaryngol Head Neck Surg; 2006 Feb; 134(2):255-9. PubMed ID: 16455374
[TBL] [Abstract][Full Text] [Related]
39. Impact of allergic rhinitis on asthma: effects on spirometric parameters.
Ciprandi G; Cirillo I; Pistorio A
Allergy; 2008 Mar; 63(3):255-60. PubMed ID: 17944984
[TBL] [Abstract][Full Text] [Related]
40. [Sublingual immunotherapy (SLIT) in the allergologist's practice].
Mösges R; Köberlein J; Keppler J
MMW Fortschr Med; 2008 Jun; 150 Suppl 2():79-84. PubMed ID: 18712127
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
